p-reality-x: real-world, overall survival with palbociclib aromatase inhibitor in hr /her2- mbc
Published 11 months ago • 312 plays • Length 14:31Download video MP4
Download video MP3
Similar videos
-
3:05
overall survival with palbociclib plus fulvestrant
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
15:53
gs3 -05: "fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection..."
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
7:09
palbociclib endocrine therapy vs capecitabine for hr-positive her2-negative breast cancer: pearl
-
2:16
what are progression free survival (pfs) and overall survival (os)?
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
3:52
#mbcnewsmonday parsifal-long study overview
-
1:05
dr. verma on palbociclib plus fulvestrant for hr /her2- breast cancer
-
2:11
what is progression free survival (pfs) and overall survival (os) in breast cancer?
-
8:39
final overall survival analysis of monarch 1
-
1:51
what does "overall survival" and "progression free survival" mean?
-
3:10
greater choice for at home palliative care program – central qld, wide bay, sunshine coast phn
-
8:09
olaparib improves disease-free survival in high-risk early-stage her2-negative breast cancer wit...